194 related articles for article (PubMed ID: 29121521)
1. Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation.
Lee JJ; Ho MC; Huang CY; Wen CH; Cheng YC; Hsu YH; Hwang DY; Lu HE; Chen HC; Hsieh PCH
Stem Cell Res; 2017 Dec; 25():83-87. PubMed ID: 29121521
[TBL] [Abstract][Full Text] [Related]
2. Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2.
Ho MC; Huang CY; Lee JJ; Hsu SH; Cheng YC; Hsu YH; Hwang DY; Lu HE; Chen HC; Hsieh PCH
Stem Cell Res; 2017 Dec; 25():38-41. PubMed ID: 29055226
[TBL] [Abstract][Full Text] [Related]
3. Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.
Huang J; Zhou S; Niu X; Hu B; Li Q; Zhang F; Zhang X; Cai X; Lou Y; Liu F; Xu C; Wang Y
Stem Cell Res Ther; 2017 Sep; 8(1):196. PubMed ID: 28927462
[TBL] [Abstract][Full Text] [Related]
4. Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes.
Lee JJ; Cheng SJ; Huang CY; Chen CY; Feng L; Hwang DY; Kamp TJ; Chen HC; Hsieh PCH
EBioMedicine; 2019 Feb; 40():675-684. PubMed ID: 30639418
[TBL] [Abstract][Full Text] [Related]
5. Generation of human induced pluripotent stem cell line (MUi026-A) from a patient with autosomal dominant polycystic kidney disease carrying PKD1 point mutation.
Maneepitasut W; Wongkummool W; Tong-Ngam P; Promthep K; Tubsuwan A; Khine Linn A; Phakdeekitcharoen B; Borwornpinyo S; Kitiyanant N; Phanthong P; Hongeng S
Stem Cell Res; 2021 May; 53():102306. PubMed ID: 33799277
[TBL] [Abstract][Full Text] [Related]
6. Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients.
Kenter AT; Rentmeester E; van Riet J; Boers R; Boers J; Ghazvini M; Xavier VJ; van Leenders GJLH; Verhagen PCMS; van Til ME; Eussen B; Losekoot M; de Klein A; Peters DJM; van IJcken WFJ; van de Werken HJG; Zietse R; Hoorn EJ; Jansen G; Gribnau JH
Stem Cells Transl Med; 2020 Apr; 9(4):478-490. PubMed ID: 32163234
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cell PLAFMCi002-A derived from peripheral blood mononuclear cells of polycystic kidney disease patient with PKD1 mutation.
Wang T; Li J; Xiao Y; Fu B; Wang P; Bai X; Cai G; Chen X; Li Q
Stem Cell Res; 2020 Dec; 49():102039. PubMed ID: 33068887
[TBL] [Abstract][Full Text] [Related]
8. Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1.
Huang CY; Ho MC; Lee JJ; Hwang DY; Ko HW; Cheng YC; Hsu YH; Lu HE; Chen HC; Hsieh PCH
Stem Cell Res; 2017 Oct; 24():139-143. PubMed ID: 29034881
[TBL] [Abstract][Full Text] [Related]
9. Establishment of the induced pluripotent stem cell line PLAFMCi006-A from peripheral blood mononuclear cells of polycystic kidney disease patients with PKD2 gene mutation.
Ma Y; Shang S; Shi M; Yang Y; Li Q; Bai XY
Stem Cell Res; 2022 Apr; 60():102681. PubMed ID: 35091308
[TBL] [Abstract][Full Text] [Related]
10.
Kuraoka S; Tanigawa S; Taguchi A; Hotta A; Nakazato H; Osafune K; Kobayashi A; Nishinakamura R
J Am Soc Nephrol; 2020 Oct; 31(10):2355-2371. PubMed ID: 32747355
[TBL] [Abstract][Full Text] [Related]
11. [Identification of a novel splicing mutation of PKD1 gene in a pedigree affected with autosomal dominant polycystic kidney disease].
Xu P; Zou Y; Li J; Huang S; Gao M; Kang R; Gao Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):778-781. PubMed ID: 27984604
[TBL] [Abstract][Full Text] [Related]
12. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
[TBL] [Abstract][Full Text] [Related]
13. Cure of ADPKD by selection for spontaneous genetic repair events in Pkd1-mutated iPS cells.
Cheng LT; Nagata S; Hirano K; Yamaguchi S; Horie S; Ainscough J; Tada T
PLoS One; 2012; 7(2):e32018. PubMed ID: 22347511
[TBL] [Abstract][Full Text] [Related]
14. Generation of two isogenic knockout PKD2 iPS cell lines, IRFMNi003-A-1 and IRFMNi003-A-2, using CRISPR/Cas9 technology.
Trionfini P; Ciampi O; Romano E; Benigni A; Tomasoni S
Stem Cell Res; 2020 Jan; 42():101667. PubMed ID: 31830647
[TBL] [Abstract][Full Text] [Related]
15. Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy.
Losekoot M; Ruivenkamp CA; Tholens AP; Grimbergen JE; Vijfhuizen L; Vermeer S; Dijkman HB; Cornelissen EA; Bongers EM; Peters DJ
J Med Genet; 2012 Jan; 49(1):37-40. PubMed ID: 22114106
[TBL] [Abstract][Full Text] [Related]
16. Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal-dominant polycystic kidney disease.
Tan YC; Blumenfeld J; Michaeel A; Donahue S; Balina M; Parker T; Levine D; Rennert H
Clin Genet; 2011 Sep; 80(3):287-92. PubMed ID: 20950398
[TBL] [Abstract][Full Text] [Related]
17. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
Hoefele J; Mayer K; Scholz M; Klein HG
Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
[TBL] [Abstract][Full Text] [Related]
18. Use of targeted sequence capture and high-throughput sequencing identifies a novel PKD1 mutation involved in adult polycystic kidney disease.
Sha YK; Sha YW; Mei LB; Huang XJ; Wang X; Lin SB; Li L; Li P
Gene; 2017 Nov; 634():1-4. PubMed ID: 28870863
[TBL] [Abstract][Full Text] [Related]
19. Novel association of familial testicular germ cell tumor and autosomal dominant polycystic kidney disease with PKD1 mutation.
Truscott L; Gell J; Chang VY; Lee H; Strom SP; Pillai R; Sisk A; Martinez-Agosto JA; Anderson M; Federman N
Pediatr Blood Cancer; 2017 Jan; 64(1):100-102. PubMed ID: 27577987
[TBL] [Abstract][Full Text] [Related]
20. The mutation-free embryo for in vitro fertilization selected by MALBAC-PGD resulted in a healthy live birth from a family carrying PKD 1 mutation.
Li W; Ma Y; Yu S; Sun N; Wang L; Chen D; Yang G; Lu S; Li Y; Yang B; Mei C
J Assist Reprod Genet; 2017 Dec; 34(12):1653-1658. PubMed ID: 28825164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
